RVB-003

N/A

Report date: 2025/04/17 11:30:45

Base Information

Drug NameRVB-003
Drug Alias NameRVB-003
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsNetherton Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesResVita Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesResVita Bio Inc
Inactive CompaniesN/A
Active IndicationsNetherton Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A